Brief: TG Therapeutics Q2 Product Revenue USD 16.036 Mln
01/08/2023 12:24
Aug 1 (Reuters) - TG Therapeutics Q2 net income USD -47.61 million. * Q2 operating income USD -44.674 million * Q2 product revenue USD 16.036 million * Q2 operating expenses USD 60.748 million
Recent news on TG Therapeutics
See all newsTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance
TG Therapeutics Q2 product revenue rises 70% on BRIUMVI sales
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj